A detailed history of Mai Capital Management transactions in Mannkind Corp stock. As of the latest transaction made, Mai Capital Management holds 53,509 shares of MNKD stock, worth $344,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,509
Previous 50,210 6.57%
Holding current value
$344,062
Previous $262,000 28.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.01 - $6.7 $16,527 - $22,103
3,299 Added 6.57%
53,509 $336,000
Q2 2024

Aug 12, 2024

SELL
$4.05 - $5.43 $13,749 - $18,434
-3,395 Reduced 6.33%
50,210 $262,000
Q1 2024

May 08, 2024

BUY
$3.25 - $5.27 $174,216 - $282,498
53,605 New
53,605 $242,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.65B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.